Recursion Pharmaceuticals, Inc design mark 019251847
"Design mark 019251847" is a figurative mark owned by Recursion Pharmaceuticals, Inc., filed at the EUIPO on September 25, 2025. It is registered and covers classes 9 and 42.
- Status
- Registered
- Since February 24, 2026
- Filed
- September 25, 2025
- Registered
- February 21, 2026
- Expires
- September 25, 2035
- Application no.
- 019251847
- Registration no.
- 019251847
- Office
- EUIPO
- European Union Intellectual Property Office
- Mark type
- Figurative mark
- 2 classes
Who owns Recursion Pharmaceuticals, Inc design mark 019251847
The owner on file, matched to the company behind it. Every owner-name spelling for that company is grouped on its page.
Owner
Recursion Pharmaceuticals, Inc.
RXRX
Representative
MÜLLER FOTTNER STEINECKE Rechtsanwälte PartmbB
MÜLLER FOTTNER STEINECKE Rechtsanwälte PartmbB
What the mark covers
The products and services Recursion Pharmaceuticals, Inc design mark 019251847 is filed for, grouped by Nice class.
Downloadable or recorded computer software for data processing for use in diagnosing medical conditions, prescribing medical treatment and prescriptions, designing clinical trials and forecasting clinical trial results, searching for clinical trial patients, analyzing medical images, analyzing data, and developing pharmaceutical products and chemical compounds
scientific and technological services, namely, medical laboratories, scientific research and design for others in the field of pharmaceuticals, conducting and evaluating clinical trials; software as a service (SaaS) featuring software to diagnose medical conditions, to prescribe medical treatment and prescriptions, to design clinical trials and forecast clinical trial results, to search for clinical trial patients, to analyze medical images, to analyze data, and to develop pharmaceutical products and chemical compounds; providing an online searchable database in the fields of pharmaceutical research and development, scientific research and development of pharmaceutical preparations, developing new uses for pharmaceutical compounds, technical research in the field of pharmaceuticals, drug use, drug discovery, and biology understanding; providing an online database in the fields of pharmaceutical research and development, scientific research and development of pharmaceutical preparations, developing new uses for pharmaceutical compounds, technical research in the field of pharmaceuticals, drug use, drug discovery, and biology understanding
What has happened so far
Steps recorded by the EUIPO, newest first.
- Bulletin 2026/036 Section B.1
- Bulletin 2025/215 Section A.1
About Recursion Pharmaceuticals, Inc design mark 019251847
Who owns the trademark "Design mark 019251847"?
The EUIPO trademark "Design mark 019251847" (application 019251847) is owned by Recursion Pharmaceuticals, Inc.
What is the status of "Design mark 019251847"?
Its status at the EUIPO is: registered.
When was "Design mark 019251847" registered?
It was registered on February 21, 2026 and is due to expire on September 25, 2035.
Get this data via the API
Everything on this page comes from the Signa API. Pull Recursion Pharmaceuticals, Inc design mark 019251847 and marks like it into your own product with one request.
GET/v1/trademarks/{id}The full record: owners, classes, dates and images
GET/v1/trademarks/{id}/eventsEvery step in the office history
GET/v1/proceedings?trademark_id={id}Oppositions and cancellations against the mark
ID=tm_019d488f-3367-74bd-9c3b-a9b1b99d6996
curl https://api.signa.so/v1/trademarks/$ID \
-H "Authorization: Bearer $SIGNA_API_KEY"{
"id": "tm_019d488f-3367-74bd-9c3b-a9b1b99d6996",
"object": "trademark",
"mark_text": "[Design Mark]",
"status": {
"primary": "active",
"stage": "registered"
},
"office_code": "EM",
"application_number": "019251847",
"filing_date": "2025-09-25",
"nice_classes": [
9,
42
],
"owners": [
{
"name": "Recursion Pharmaceuticals, Inc.",
"entity_id": "ent_019ebbda-06dd-75e8-9396-455bd72c33a6"
}
]
}